Prevalence and risk factors for aspirin resistance in elderly patients with type 2 diabetes

International Journal of Gerontology

Volumn 5, Issue 2, 2011, Pages 112-116

  Liu, Lin ^a   Cao, Jian ^a   Fan, Li ^a   Hu, Guoliang ^a   Hu, Yixin ^a   Zhu, Binpo ^a   Li, Xiaoli ^a   Wang, Hao ^a   Bai, Jie ^a   Shi, Haiyan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

aspirin resistance; diabetes mellitus type 2; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ARACHIDONIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ASPIRIN RESISTANCE; DRUG RESPONSE; FATTY ACID BLOOD LEVEL; FEMALE; GERIATRIC PATIENT; HEMATOLOGICAL PROCEDURES; HUMAN; HUMAN TISSUE; LIGHT TRANSMISSION AGGREGOMETRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOELASTOGRAPHY;

EID: 79960565509     PISSN: 18739598     EISSN: 1873958X     Source Type: Journal    
DOI: 10.1016/j.ijge.2011.04.016     Document Type: Article

References (30)

1. A.J. Sinclair, I.E. Robert, and S.C. Croxson Mortality in older people with diabetes mellitus Diabet Med 14 1997 639 647 (Pubitemid 27346852)
2. P. Ambrosi, P. Villani, and G. Bouvenot Antiplatelet therapy for primary prevention in diabetes Diabetes Metab 32 2006 2S52-2S56
3. M. Sacco, F. Pellegrini, and M.C. Roncaglioni Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial Diabetes Care 26 2003 3264 3272 (Pubitemid 37466885)
4. R. Ajjan, R.F. Storey, and P.J. Grant Aspirin resistance and diabetes mellitus Diabetologia 5 2008 385 390
5. D.T. Ertugrul, E. Tutal, and M. Yildiz Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus J Clin Endocrinol Metab 95 2010 2897 2901
6. J. DiChiara, K.P. Bliden, and U.S. Tantry The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study Diabetes 56 2007 3014 3019 (Pubitemid 350223637)
7. P.A. Gum, K. Kottke-Marchant, and E.D. Poggio Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235 (Pubitemid 32721947)
8. P.A. Gurbel, K. Bliden, and J. DiChiara Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study Circulation 115 2007 3156 3164 (Pubitemid 47012230)
9. S. Fateh-Moghadam, U. Plockinger, and N. Cabeza Prevalence of aspirin resistance in patients with type 2 diabetes Acta Diabetol 42 2005 99 103 (Pubitemid 40881115)
10. H.W. Cohen, J.P. Crandall, and S.M. Hailpern Aspirin resistance associated with HbA1c and obesity in diabetic patients J Diabetes Complications 22 2008 224 228 (Pubitemid 351539062)
11. G. Kahraman, T. Sahin, and T. Kilic The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome Int J Cardiol 115 2007 391 396 (Pubitemid 46188589)
12. A. Araki Homocysteine and diabetic macroangiopathy Nippon Rinsho 64 2006 2153 2158 [in Japanese]
13. U. Tantry, K. Bliden, and P.A. Gurbel Overestimation of platelet aspirin resistance detection by thromboelastograph platelet mapping and validation by conventional aggreagometry using arachidonic acid stimulation J Am Coll Cardiol 46 2005 1705 1709 (Pubitemid 41531626)
14. E.I. Lev, R.T. Patel, and K.J. Maresh Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance J Am Coll Cardiol 47 2006 27 33 (Pubitemid 43005160)
15. N.G. Dussaillant, M.M. Zapata, and B.P. Fardella Frequency and characteristics of aspirin resistance in Chilean cardiovascular patients Rev Med Chil 133 2005 409 417 [in Spanish] (Pubitemid 43126734)
16. M. Lordkipanidze, C. Pharand, and E. Schampaert A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 2007 1702 1708 (Pubitemid 47227104)
17. A.D. Michelson Methods for the measurement of platelet function Am J Cardiol 103 2009 20A 26A
18. H. Zbidi, P.C. Redondo, and J.J. Lopez Homocysteine induces caspase activation by endoplasmic reticulum stress in platelets from type 2 diabetics and healthy donors Thromb Haemost 103 2010 1022 1032
19. S. Gonzalez, J.M. Huerta, and S. Fernandez Homocysteine increases the risk of mortality in elderly individuals Br J Nutr 97 2007 1138 1143 (Pubitemid 46925366)
20. S.C. De Jong, M. Van den Berg, and J.A. Rauwerda Hyperhomocysteinemia and atherothrombotic disease Semin Thromb Hemost 24 1998 381 385 (Pubitemid 28440715)
21. D.W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin Chem 44 1998 1833 1843 (Pubitemid 28368904)
22. R.F. Zanin, L.F. Campesato, and E. Braganhol Homocysteine decreases extracellular nucleotide hydrolysis in rat platelets Thromb Res 125 2009 e87 e92
23. B.T.G.E. Ivandic, P. Schlick, and P. Staritz Determination of aspirin responsiveness by use of whole blood platelet aggregometry Clin Chem 53 2007 614 619 (Pubitemid 46580230)
24. H. Shen, W. Herzog, and M. Drolet Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study) Am J Cardiol 104 2009 606 612
25. D.M. Becker, J. Segal, and D. Vaidya Sex differences in platelet reactivity and response to low-dose aspirin therapy JAMA 295 2006 1420 1427
26. D. Skowasch, A. Viktor, and M. Schneider-Schmitt Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril Clin Res Cardiol 95 2006 212 216
27. A. Schafer, D. Fraccarollo, and M. Eigenthaler Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability Arterioscler Thromb Vasc Biol 25 2005 1071 1077 (Pubitemid 40627857)
28. R. Ajjan, and P.J. Grant Coagulation and atherothrombotic disease Atherosclerosis 186 2006 240 259
29. M.T. Santos, M.P. Fuset, and M. Ruano Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction Am J Cardiol 104 2009 1618 1623
30. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment Diabetes 54 2005 2430 2435 (Pubitemid 41134272)